Charles River Laboratories Introduces Groundbreaking Animal-Free Bacterial Endotoxin Test
Charles River Laboratories International, Inc. has made a significant breakthrough in the field of bacterial endotoxin testing (BET) by launching the Endosafe Trillium rCR cartridge offering. This new innovation combines the company’s flagship Endosafe cartridge technology with their recombinant cascade reagent (rCR), marking the first rapid animal-free BET solution in the market.
The Endosafe Trillium rCR cartridge provides a reliable and animal-free alternative for BET, a critical test required by regulatory authorities to ensure the safety of pharmaceuticals and medical devices. Traditionally, this test has involved the use of animal-based methods, causing concerns regarding animal welfare and potential ethical issues. With the introduction of this new cartridge, Charles River Laboratories aims to address these concerns and offer an innovative solution to the industry.
The utilization of the recombinant cascade reagent in the Endosafe Trillium rCR cartridge is key to its success. This reagent mimics the response human blood has to endotoxins, providing a sensitive and accurate BET method. By eliminating the need for animal-derived products, companies can minimize ethical considerations and streamline the testing process, saving time and resources.
This state-of-the-art cartridge is an extension of Charles River’s Trillium rCR vial and offers an expanded portfolio of BET testing solutions. The company’s commitment to advancing this technology showcases its dedication to providing innovative and sustainable solutions for the pharmaceutical and medical device industry.
The introduction of an animal-free BET test comes at a pivotal time when the industry is increasingly focusing on reducing its reliance on animal testing and exploring alternative testing methods. Charles River Laboratories’ Endosafe Trillium rCR cartridge positions the company as a leader in meeting these evolving industry demands.
As regulatory authorities continue to emphasize the importance of animal welfare and technology advancements, the Endosafe Trillium rCR cartridge presents a timely solution that aligns with these goals. By offering a rapid, accurate, and animal-free BET method, Charles River Laboratories is poised to revolutionize the field and contribute to the industry’s collective efforts towards a more sustainable future.
Comments